NO823422L - ALKALIMETAL SALTS OF POLY (VINYL BENZOIC ACID) AS AN AGENT FOR PLAQUE ON TENNES. - Google Patents
ALKALIMETAL SALTS OF POLY (VINYL BENZOIC ACID) AS AN AGENT FOR PLAQUE ON TENNES.Info
- Publication number
- NO823422L NO823422L NO823422A NO823422A NO823422L NO 823422 L NO823422 L NO 823422L NO 823422 A NO823422 A NO 823422A NO 823422 A NO823422 A NO 823422A NO 823422 L NO823422 L NO 823422L
- Authority
- NO
- Norway
- Prior art keywords
- plaque
- poly
- teeth
- preparation
- sodium
- Prior art date
Links
- -1 ALKALIMETAL SALTS Chemical class 0.000 title claims description 35
- 229910052783 alkali metal Inorganic materials 0.000 title claims description 6
- XUDBVJCTLZTSDC-UHFFFAOYSA-N 2-ethenylbenzoic acid Chemical class OC(=O)C1=CC=CC=C1C=C XUDBVJCTLZTSDC-UHFFFAOYSA-N 0.000 title claims description 4
- 239000003795 chemical substances by application Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 claims description 20
- 208000002064 Dental Plaque Diseases 0.000 claims description 8
- 229920000642 polymer Polymers 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 5
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 claims description 4
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 230000000675 anti-caries Effects 0.000 claims description 2
- 229920001519 homopolymer Polymers 0.000 claims description 2
- 229910052744 lithium Inorganic materials 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 239000011775 sodium fluoride Substances 0.000 claims description 2
- 235000013024 sodium fluoride Nutrition 0.000 claims description 2
- 239000000203 mixture Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 238000009472 formulation Methods 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 239000012754 barrier agent Substances 0.000 description 6
- 230000008021 deposition Effects 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 230000004888 barrier function Effects 0.000 description 5
- 238000002156 mixing Methods 0.000 description 4
- 239000002324 mouth wash Substances 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical class O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003349 gelling agent Substances 0.000 description 3
- 229920002389 poly(4-vinylbenzoate) Polymers 0.000 description 3
- 239000000606 toothpaste Substances 0.000 description 3
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
- IRQWEODKXLDORP-UHFFFAOYSA-N 4-ethenylbenzoic acid Chemical compound OC(=O)C1=CC=C(C=C)C=C1 IRQWEODKXLDORP-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 230000001013 cariogenic effect Effects 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229920001477 hydrophilic polymer Polymers 0.000 description 2
- 229940051866 mouthwash Drugs 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229940034610 toothpaste Drugs 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- SIHSSUWJKIEVGQ-UHFFFAOYSA-N 14-methyl-1-(14-methylpentadecoxy)pentadecane Chemical compound CC(C)CCCCCCCCCCCCCOCCCCCCCCCCCCCC(C)C SIHSSUWJKIEVGQ-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241001132374 Asta Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 229920003091 Methocel™ Polymers 0.000 description 1
- 102000001621 Mucoproteins Human genes 0.000 description 1
- 108010093825 Mucoproteins Proteins 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229920002415 Pluronic P-123 Polymers 0.000 description 1
- 229920002057 Pluronic® P 103 Polymers 0.000 description 1
- 229920002059 Pluronic® P 104 Polymers 0.000 description 1
- 229920002065 Pluronic® P 105 Polymers 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 239000008376 breath freshener Substances 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005115 demineralization Methods 0.000 description 1
- 230000002328 demineralizing effect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 150000004673 fluoride salts Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 229920001992 poloxamer 407 Polymers 0.000 description 1
- 238000000710 polymer precipitation Methods 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 239000012487 rinsing solution Substances 0.000 description 1
- 230000009291 secondary effect Effects 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 229940079862 sodium lauryl sarcosinate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- ADWNFGORSPBALY-UHFFFAOYSA-M sodium;2-[dodecyl(methyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCN(C)CC([O-])=O ADWNFGORSPBALY-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 108010050327 trypticase-soy broth Proteins 0.000 description 1
Landscapes
- Dental Preparations (AREA)
- Cosmetics (AREA)
Description
Foreliggende oppfinnelse vedrører munnhygieniske preparater og metoder for bruk av slike preparater for å hindre festing av bakterier til tenner. Mer spesielt angår oppfinnelsen visse alkalimetallsalter av poly(vinylbenzosyre) som er funnet nyttige med hensyn til inhibering av agglutineringen av orale mikrober til tenner. The present invention relates to oral hygiene preparations and methods for using such preparations to prevent the attachment of bacteria to teeth. More particularly, the invention relates to certain alkali metal salts of poly(vinylbenzoic acid) which have been found useful in inhibiting the agglutination of oral microbes to teeth.
Hindringen av avsetningen av dentalplaque på tenner er ét meget ønsket resultat. Dentalplaque resulterer når kariogene bakterier aggregeres i kolonier på overflaten av tenner og danner en vedhengende avsetning derpå. Tilstedeværelsen av plaque på tenner antas å være forløperen til utvikling av gingivitt, dental karies og periodontitt. The prevention of the deposition of dental plaque on teeth is one highly desired result. Dental plaque results when cariogenic bacteria aggregate in colonies on the surface of teeth and form an adherent deposit thereon. The presence of plaque on teeth is believed to be the precursor to the development of gingivitis, dental caries and periodontitis.
Mens mange forsøk har blitt foretatt for å regulere effekt-ene av kariogene bakterier og den dentale plaque som de frem-bringer, f.eks. fluorid-, tanntråd-, børstebehandling, osv., er disse typisk beregnet for enten å motvirke de sekundære effekter av plaque på tennene og tannkjøttet, eller fjerning av plaque som allerede er dannet på og adherer til tennene While many attempts have been made to regulate the effects of cariogenic bacteria and the dental plaque they produce, e.g. fluoride, flossing, brushing, etc., these are typically intended to either counteract the secondary effects of plaque on the teeth and gums, or remove plaque that has already formed on and adheres to the teeth
og omgivende vev. Slike behandlinger er imidlertid ikke fullstendig vellykkede og må suppleres med periodisk behand-ling av personell innen tannbehandlingsprofesjonen. Hittil foreligger ingen kommersielt gjennomførlig hjemmebehand-lingsmetode for hindring av dannelse av plaque eller dens adhesjon til tenner. and surrounding tissue. However, such treatments are not completely successful and must be supplemented with periodic treatment by personnel within the dental treatment profession. Until now, there is no commercially feasible home treatment method for preventing the formation of plaque or its adhesion to teeth.
Visse alkalimetallsalter av poly(vinylbenzosyre) er funnetCertain alkali metal salts of poly(vinylbenzoic acid) have been found
å inhibere avsetningen av dentalplaque på tenner hosto inhibit the deposition of dental plaque on teeth in
mennesker når de påføres fra forskjellige tann<p>astaer, munn-skylleoppløsninger, eller andre munnhygieniske metoder. Disse hydrofile polymerer er vesentlig oppløselige i vann eller bærere av vann/organisk oppløsningsmiddel og har gode humans when applied from various dental<p>astas, mouth-rinse solutions, or other oral hygiene methods. These hydrophilic polymers are substantially soluble in water or water/organic solvent carriers and have good
■ filmdannende egenskaper. Mens virkningsmekanismen til de hydrofile polymere filmene når det gjelder å retardere plaqueavsetning ikke er kjent med absolutt sikkerhet, antas det at filmene av anionisk ladede polymerer avsatt på tenner bevirker en felles repulsjon mellom den negativt ladede poly- ■ film-forming properties. While the mechanism of action of the hydrophilic polymer films in retarding plaque deposition is not known with absolute certainty, it is believed that the films of anionically charged polymers deposited on teeth cause a mutual repulsion between the negatively charged poly-
merfilm og de negativt ladede mikroorganismer som er ansvar-lig for plaqueutvikling. De polymere saltene ifølge oppfinnelsen er særlig effektive som komponenter i tann- merfilm and the negatively charged microorganisms responsible for plaque development. The polymeric salts according to the invention are particularly effective as components of dental
pastaer eller andre munnhygieniske preparater når det gjelder å redusere dentalplaque-avsetning på tenner. pastes or other oral hygiene preparations when it comes to reducing dental plaque deposition on teeth.
De hydrofile, polymere saltene som er funnet nyttige for regulering av dentalplaque ifølge foreliggende oppfinnelse er vesentlig alkalimetallsalter av homopolymerene av vinylbenzosyre, hvor den gjentagende enhet i polymeren er rep-resentert ved strukturen (A): The hydrophilic, polymeric salts which have been found useful for controlling dental plaque according to the present invention are essentially alkali metal salts of the homopolymers of vinylbenzoic acid, where the repeating unit in the polymer is represented by the structure (A):
hvor M er valgt fra gruppen bestående av natrium, kalium og litium. where M is selected from the group consisting of sodium, potassium and lithium.
De poly(vinylbenzosyre)polymerene som er nødvendige som mellomprodukter for fremstilling av saltene med struktur (A), kan lett fremstilles ved friradikal-polymerisasjon av vinyl-benzosyremonomerer, slik som 4-vinylbenzosyre. Nøytralisering av poly(vinylbenzosyre)polymerene med alkalimetallhydroksyder eller tilsetning av i det minst støkiometriske mengder av et alkalimetalloksyd, -karbonat, -klorid, -nitriat, -acetat eller -sulfat, er tilstrekkelig til å frembringe polymer-saltene ifølge oppfinnelsen. Om Ønsket kan de vandige opp-løsningene av de polymere saltene renses ved dialyse og den dialyserte polymeroppløsning frysetørkes, spraytørkes eller fordampes for oppnåelse av de polymere saltene i fast form. The poly(vinylbenzoic acid) polymers which are necessary as intermediates for the preparation of the salts of structure (A) can be easily prepared by free radical polymerization of vinylbenzoic acid monomers, such as 4-vinylbenzoic acid. Neutralization of the poly(vinylbenzoic acid) polymers with alkali metal hydroxides or addition of at least stoichiometric amounts of an alkali metal oxide, carbonate, chloride, nitrate, acetate or sulfate is sufficient to produce the polymer salts according to the invention. If desired, the aqueous solutions of the polymeric salts can be purified by dialysis and the dialyzed polymer solution freeze-dried, spray-dried or evaporated to obtain the polymeric salts in solid form.
Alkalimetallsaltene av foreliggende poly(vinylbenzosyre)-polymerer er meget effektive når det gjelder å redusere avsetningen av plaque ved in vitro-forsøk. Natriumpoly(4-vinylbenzoat) fremstilt fra poly(4-vinylbenzosyre) viste f.eks. en reduksjon på 91% i avsetningen av plaque ved for- søk. Den benyttede in vitro-forsøksmetode begynner med vekst" av plaque i små beholdere inneholdende steriliserte trypti-case-media som har blitt supplert med sukrose. Typisk blir 10 beholdere enkeltvis inokulert med 0,5 ml "unpooled" The alkali metal salts of the present poly(vinylbenzoic acid) polymers are very effective in reducing the deposition of plaque in in vitro experiments. Sodium poly(4-vinylbenzoate) prepared from poly(4-vinylbenzoic acid) showed e.g. a reduction of 91% in the deposition of plaque during trials. The in vitro experimental method used begins with the growth of plaque in small containers containing sterilized trypti-case media which has been supplemented with sucrose. Typically 10 containers are individually inoculated with 0.5 ml of unpooled
friskt oppsamlet plaque fra 10 personer. I en kontroll-freshly collected plaque from 10 people. In a control
serie blir et fordestillert preparatglass eller en uttrykket mennesketann innført i hver beholder. I testseriene forbe-handles tannen eller preparatglasset med en 1% oppløsning av testforbindelsen (oppløst i vann eller en annen bærer), får tørke for å avsette en tynn film av forbindelsen på overflaten, og preparatglasset eller tannen anbringes i vekstmediet. Be-holderne inkuberes under anaerobe betingelser i to dager ved 37°C. Tannen eller preparatglasset fjernes, lufttørkes og flekkes med 0,15% "FD&C#3" fargestoffoppløsning for å series, a pre-distilled preparation glass or an expressed human tooth is introduced into each container. In the test series, the tooth or specimen slide is pretreated with a 1% solution of the test compound (dissolved in water or another carrier), allowed to dry to deposit a thin film of the compound on the surface, and the specimen slide or tooth is placed in the growth medium. The containers are incubated under anaerobic conditions for two days at 37°C. The tooth or slide is removed, air-dried and stained with 0.15% "FD&C#3" dye solution to
vise de akkumulerte plaqueavsetninger. Tannen eller preparatglasset bedømmes for plaquetetthet ved anvendelse av en målestokk fra 0 til 5. Plaquebarriere-aktivitet rapporteres som % gjennomsnitt plaquereduksjon sammenlignet med hen-siktsmessige kontroller for 10 personer. show the accumulated plaque deposits. The tooth or preparation glass is assessed for plaque density using a scale from 0 to 5. Plaque barrier activity is reported as % average plaque reduction compared to appropriate controls for 10 subjects.
Eksempel 1Example 1
Natriumpoly( 4- vinylbenzoat)Sodium poly(4- vinyl benzoate)
En suspensjon av 4,0 g (0,027 mol) 4-vinylbenzosyre og 0,04 g azobisisobutyronitril i 25 ml benzen ble oppvarmet under nitrogen ved 80°C i ca. 8 timer, og iløpet av denne tiden fant det sted en sterk polymerutfelling. Suspensjonen ble avkjølt til romtemperatur, fortynnet med 25 ml benzen og filtert og dette ga 4,0 g poly(4-vinylbenzosyre). A suspension of 4.0 g (0.027 mol) of 4-vinylbenzoic acid and 0.04 g of azobisisobutyronitrile in 25 ml of benzene was heated under nitrogen at 80°C for approx. 8 hours, during which time a strong polymer precipitation took place. The suspension was cooled to room temperature, diluted with 25 ml of benzene and filtered to give 4.0 g of poly(4-vinylbenzoic acid).
En oppløsning av 1,6638 g poly(4-vinylbenzosyre) i 30 ml metanol ble justert fra pH 2,5 til pH 11,0 med 23,3 ml 0,4 80 N metanolisk natriumhydroksyd. Den resulterende opp-løsning ble oppløsningsmiddelstrippet til hvitt fast stoff av natriumpoly(4-vinylbenzoat). NMR- og IR-spektra var i overensstemmelse med strukturen for det polymere salt. A solution of 1.6638 g of poly(4-vinylbenzoic acid) in 30 ml of methanol was adjusted from pH 2.5 to pH 11.0 with 23.3 ml of 0.4 80 N methanolic sodium hydroxide. The resulting solution was solvent stripped to white solid of sodium poly(4-vinylbenzoate). NMR and IR spectra were consistent with the structure of the polymeric salt.
Foreliggende plaquebarriere-munnpreparater kan omfatte en hvilken som helst konvensjonell farmasøytisk akseptabel munnhygienisk formulering som inneholder (og er forenelig med) en effektiv mengde av et plaquebarrieremiddel som definert heri. Slike formuleringer innbefatter f.eks. munn-vann, skyllevann, utskyllingsoppløsninger, ikke-slipende geltannpastaer, tannprotese-rensemidler, belagt tanntråd og interdentale stimulatorbelegg, tyggegummier, pastiller, middel for friskere pust, skum og spraymidler. Present plaque barrier oral formulations may comprise any conventional pharmaceutically acceptable oral hygiene formulation containing (and compatible with) an effective amount of a plaque barrier agent as defined herein. Such formulations include e.g. mouthwashes, rinses, rinsing solutions, non-abrasive gel toothpastes, denture cleaners, coated dental floss and interdental stimulator coatings, chewing gums, lozenges, breath fresheners, foams and sprays.
Plaquebarrieremidlene kan være tilstede i disse fomuleringer i effektive konsentrasjoner vanligvis i området fra ca. 0,05 vekt-% til så meget som 30 vekt-% eller grensen for forene-lighet med bæreren. Ingen fordel vil imidlertid bli oppnådd fra konsentrasjoner over ca. 20 vekt-%. Et foretrukket konsentrasjonsområde for plaquebarrieremidlene i formulering-ene ifølge oppfinnelsen er fra ca. 0,5 til ca. 10 vekt-%. The plaque barrier agents may be present in these formulations in effective concentrations usually in the range of about 0.05% by weight to as much as 30% by weight or the limit of compatibility with the carrier. However, no benefit will be obtained from concentrations above approx. 20% by weight. A preferred concentration range for the plaque barrier agents in the formulations according to the invention is from approx. 0.5 to approx. 10% by weight.
Et mer foretrukket område er fra ca. 2 til ca. 8 vekt-%, idet ca. 5% er den i øyeblikket mest foretrukne konsentrasjon i en ikke-slipende gelbærer. A more preferred area is from approx. 2 to approx. 8% by weight, with approx. 5% is currently the most preferred concentration in a non-abrasive gel carrier.
pH-verdien til disse plaquebarriere-preparatene bør være mellom pH 5,0 og 10,0, fortrinnsvis mellom pH 5,0 og 8,0, mer foretrukket mellom ca. pH 6,0 og 7,5. Lavere pH-verdi enn 5,0 er uønsket på grunn av den mulige forøkelse av emalje-demineralisering. The pH value of these plaque barrier preparations should be between pH 5.0 and 10.0, preferably between pH 5.0 and 8.0, more preferably between about pH 6.0 and 7.5. Lower pH values than 5.0 are undesirable due to the possible increase in enamel demineralization.
Egnede konvensjonelle farmasøytisk akseptable bærere som kan benyttes med plaquebarrieremidlene for fremstilling av barrierepreparatene ifølge oppfinnelsen, kan omfatte vann, etanol; slike fuktemidler som propylenglykol, glycerol og sorbitol; slike geldannelsesmidler som cellulosederivater, f.eks. "Methocel", karboksymetylcellulose ("CMC 7MF") og "Klucel HF", polyoksypropylen/polyoksyetylen-blokk-kopoly-merer, f.eks. "Pluronic F-127", "Pluronic F-108", "Pluronic P-103", "Pluronic P-104", "Pluronic P-105" og "Pluronic P-123", kolloidale magnesiumalluminiumsilikat-komplekser slik som "Veegum", og mucoprotein-fortykningsmidler slik som "Carbopol 934"; gelstabilisatorer slik som silisium-dioksydene, f.eks. "Cab-O-Sil M5" og polyvinylpyrrolidon; søtningsstoffer slik som natriumsakkarin; preserverings-midler slik som sitronsyre, natriumbenzoat, cetylpyridinium-klorid, kaliumsorbat, metyl- og etylparabener; detergenter slik som natriumlaurylsulfat, natriumkokosmonoglycerid-sulfonat, natriumlaurylsarkosinat og polyoksyetyleniso-heksadecyleter ("Arlasolve 200") og godkjente farger og smaksstoffer. Anti-karies-fluoridforbindelser slik som natriumfluorid, kan også inkorporeres i foreliggende preparater . Suitable conventional pharmaceutically acceptable carriers which can be used with the plaque barrier agents for the preparation of the barrier preparations according to the invention may include water, ethanol; such humectants as propylene glycol, glycerol and sorbitol; such gelling agents as cellulose derivatives, e.g. "Methocel", carboxymethylcellulose ("CMC 7MF") and "Klucel HF", polyoxypropylene/polyoxyethylene block copolymers, e.g. "Pluronic F-127", "Pluronic F-108", "Pluronic P-103", "Pluronic P-104", "Pluronic P-105" and "Pluronic P-123", colloidal magnesium aluminum silicate complexes such as "Veegum ", and mucoprotein thickeners such as "Carbopol 934"; gel stabilizers such as the silicon dioxides, e.g. "Cab-O-Sil M5" and polyvinylpyrrolidone; sweeteners such as sodium saccharin; preservatives such as citric acid, sodium benzoate, cetylpyridinium chloride, potassium sorbate, methyl and ethyl parabens; detergents such as sodium lauryl sulfate, sodium coco monoglyceride sulfonate, sodium lauryl sarcosinate and polyoxyethylene iso-hexadecyl ether ("Arlasolve 200") and approved colors and flavors. Anti-caries fluoride compounds such as sodium fluoride can also be incorporated into the present preparations.
Følgende spesifikke eksempler illustrerer ytterligere foreliggende plaquebarriere-preparater. The following specific examples further illustrate the present plaque barrier compositions.
Eksempel A - MunnvannoppløsningExample A - Mouthwash solution
Eksempel B - Munnvannoppløsning Example B - Mouthwash solution
Eksempel C - Slipende tannpastagel Eksempel D - Tyggegummi Eksempel E - Ikke-slipende geltannpasta Example C - Abrasive toothpaste gel Example D - Chewing gum Example E - Non-abrasive gel toothpaste
Eksempel F Example F
Følgende formulering illusterer et i øyeblikket foretrukket ikke-slipende gelpreparat inneholdende et barrieremiddel ifølge foreliggende oppfinnelse. The following formulation illustrates a currently preferred non-abrasive gel preparation containing a barrier agent according to the present invention.
Mens detaljene for fremstilling av alle de ovenfor angitte formuleringer er velkjente for fagmannen, skal det for fullstendighetens skyld beskrives en foreslått metode for fremstilling av gelpreparatet i dette eksempel. While the details for the preparation of all of the above-mentioned formulations are well known to those skilled in the art, for the sake of completeness, a proposed method for the preparation of the gel preparation shall be described in this example.
I en første beholder blandes vannet, natriumsakkarin, natriumbenzoat og fargestoffer. Deretter anbringes beholderen i et isbad. Når temperaturen når 6°C, tilsettes geldannelses-midlet og innholdet blandes langsomt inntil geldannelses-midlet er oppløst. Deretter oppvarmes oppløsningen til 70°C. In a first container, the water, sodium saccharin, sodium benzoate and dyes are mixed. The container is then placed in an ice bath. When the temperature reaches 6°C, the gelling agent is added and the contents are mixed slowly until the gelling agent is dissolved. The solution is then heated to 70°C.
Til en annen beholder tilsettes glycerinet. Deretter tilsettes "Cab-O-Sil M5" ved dryssing under blanding. Etter dette tilsettes plaquebarrieremidlet og blanding fortsettes til en jevn pasta. Pastaen oppvarmes deretter i et vann- Add the glycerin to another container. Then add "Cab-O-Sil M5" by sprinkling while mixing. After this, the plaque barrier agent is added and mixing is continued to a smooth paste. The pasta is then heated in a water
bad under blanding til en temperatur på 70°C.bath while mixing to a temperature of 70°C.
Innholdet i den første beholderen tilsettes til den andre beholderen og sammenblandes inntil satsen er homogen mens temperaturen holdes ved 70°C. Deretter tilsettes smaks-stoff, all blanding stoppes, og sammensetningen får sedi-mentere i omtrent 1 time. Dersom det er nødvendig å fjerne luftbobler, kan kjøling natten over benyttes. The contents of the first container are added to the second container and mixed until the batch is homogeneous while maintaining the temperature at 70°C. Flavoring is then added, all mixing is stopped, and the composition is allowed to settle for about 1 hour. If it is necessary to remove air bubbles, cooling overnight can be used.
Disse preparater benyttes fortrinnsvis fra 1 til 3 ganger ' - daglig i et rutinemessig munnhygieneprogram for å hindre festing av plaque til tennene. These preparations are preferably used from 1 to 3 times a day in a routine oral hygiene program to prevent plaque from attaching to the teeth.
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO823422A NO823422L (en) | 1982-10-13 | 1982-10-13 | ALKALIMETAL SALTS OF POLY (VINYL BENZOIC ACID) AS AN AGENT FOR PLAQUE ON TENNES. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO823422A NO823422L (en) | 1982-10-13 | 1982-10-13 | ALKALIMETAL SALTS OF POLY (VINYL BENZOIC ACID) AS AN AGENT FOR PLAQUE ON TENNES. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO823422L true NO823422L (en) | 1984-04-16 |
Family
ID=19886755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO823422A NO823422L (en) | 1982-10-13 | 1982-10-13 | ALKALIMETAL SALTS OF POLY (VINYL BENZOIC ACID) AS AN AGENT FOR PLAQUE ON TENNES. |
Country Status (1)
| Country | Link |
|---|---|
| NO (1) | NO823422L (en) |
-
1982
- 1982-10-13 NO NO823422A patent/NO823422L/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4362713A (en) | Salts of maleic acid copolymers as dental plaque barrier agents | |
| US11779526B2 (en) | Oral care compositions | |
| US6124374A (en) | Antimicrobial denture adhesive and cleanser compositions | |
| US5015467A (en) | Combined anticalculus and antiplaque compositions | |
| US10098830B2 (en) | Oral care compositions | |
| EP2996777B1 (en) | Oral care compositions | |
| CA1176795A (en) | Sulfonated polyamino acids as dental plaque barriers | |
| NO165903B (en) | ORAL AND DENTAL CARE. | |
| US4362712A (en) | Carboxylated naphthalene formaldehyde condensation polymers as dental plaque barriers | |
| US4375461A (en) | Sulfonated vinyl aromatic homopolymers and copolymers as dental plaque barriers | |
| US4364927A (en) | Sulfonated naphthalene formaldehyde condensation polymers as dental plaque barriers | |
| US4403089A (en) | Carboxylated naphthalene formaldehyde condensation polymers as dental plaque barriers | |
| US4364924A (en) | Alkali metal salts of poly(vinylbenzoic acid) as dental plaque barrier agents | |
| US4360515A (en) | Sulfonated alkoxynaphthalenes as dental plaque barriers | |
| US4361547A (en) | Sulfonated aromatic formaldehyde condensation polymers as dental plaque barriers | |
| EP2996665B1 (en) | Oral care compositions | |
| NO823422L (en) | ALKALIMETAL SALTS OF POLY (VINYL BENZOIC ACID) AS AN AGENT FOR PLAQUE ON TENNES. | |
| EP0105983A1 (en) | Alkali metal salts of poly(vinylbenzoic acid) as dental plaque barrier agents | |
| US4307077A (en) | Sulfonated bis(naphthoxy)alkanes as dental plaque barriers | |
| JPS5988416A (en) | Oral sanitary composition | |
| US4307078A (en) | Sulfonated bis(alkylphenoxy)alkanes as dental plaque barriers | |
| CA1190150A (en) | Alkali metal salts of poly(vinylbenzoic acid) as dental plaque barrier agents | |
| NZ202196A (en) | Oral hygiene compositions containing alkali metal salts of a homopolymer of vinylbenzoic acid | |
| IE51424B1 (en) | Sulfonated poly(arylene ether sulfone)polymers as dental plaque barriers | |
| JPH04120014A (en) | Composition for oral cavity |